Skip to main content
Vaxart, Inc. (VXRT)
NASDAQ: VXRT · Real-Time Price · USD
0.620
+0.016 (2.70%)
Dec 20, 2024, 4:00 PM EST - Market closed

Vaxart Revenue

Vaxart had revenue of $4.93M in the quarter ending September 30, 2024, with 134.79% growth. This brings the company's revenue in the last twelve months to $16.76M, up 303.27% year-over-year. In the year 2023, Vaxart had annual revenue of $7.38M with 6,796.26% growth.

Revenue (ttm)
$16.76M
Revenue Growth
+303.27%
P/S Ratio
6.68
Revenue / Employee
$153,761
Employees
109
Market Cap
140.95M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20237.38M7.27M6,796.26%
Dec 31, 2022107.00K-785.00K-88.00%
Dec 31, 2021892.00K-3.15M-77.95%
Dec 31, 20204.05M-5.82M-58.97%
Dec 31, 20199.86M5.70M137.12%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Nevro 419.15M
Puma Biotechnology 243.57M
Sutro Biopharma 160.96M
Compugen 59.85M
Metagenomi 55.08M
Seer, Inc. 14.61M
Aligos Therapeutics 6.00M
Revenue Rankings

VXRT News

More News